SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-077763
Filing Date
2022-12-06
Accepted
2022-12-06 07:00:22
Documents
4
Period of Report
2022-12-06

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea169698-6k_tizianalife.htm 6-K 13182
2 TIZIANA LIFE SCIENCES LTD NOTICE OF THE 2022 ANNUAL GENERAL MEETING OF SHAREHOLD ea169698ex99-1_tiziana.htm EX-99.1 16825
3 NEWS SERVICE ANNOUNCEMENT, DATED DECEMBER 6, 2022 ea169698ex99-2_tiziana.htm EX-99.2 5600
4 GRAPHIC ex99-1_001.jpg GRAPHIC 6342
  Complete submission text file 0001213900-22-077763.txt   45615
Mailing Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB
Business Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB 0044(0) 207-495-2379
Tiziana Life Sciences Ltd (Filer) CIK: 0001723069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38723 | Film No.: 221446673
SIC: 2834 Pharmaceutical Preparations